Document Detail


Medical abortion: outcomes in a family medicine setting.
MedLine Citation:
PMID:  20616293     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: To compare outcomes of early medical abortion with mifepristone and misoprostol in a family medicine setting and specialized reproductive health clinics. METHODS: This study used data collected from a prospective, open-label, randomized trial of oral versus buccal misoprostol efficacy. A secondary analysis was performed, evaluating efficacy, acceptability, and interventions after medication at the family medicine site compared with the 6 specialized reproductive health sites. RESULTS: Comparing data from patients in the family medicine setting (n = 116) to specialized reproductive health sites (n = 731) revealed no difference in overall efficacy (95.7% vs 93.4%; P = .351). The family medicine site used a second dose of misoprostol more frequently than the other sites (6.9% vs 2.5%; P = .018). In addition, uterine aspiration after medical abortion at the family medicine site was not used for "medically necessary" reasons whereas reproductive health clinics used it 2.6% of the time (marginally significant; P = .094). Patient satisfaction at family medicine sites was comparable to the other sites (91.2% vs 92.0%; P = .792). CONCLUSION: Medical abortion has similar efficacy and patient satisfaction when offered in a family medicine practice or at a reproductive health specialty clinic. These findings should reassure family physicians that medical abortion can be offered safely in their practices.
Authors:
Linda Prine; Caitlin Shannon; Ginger Gillespie; William A Crowden; Jennifer Fortin; Michelle Howe; Ilana Dzuba
Related Documents :
12861463 - Declining interest in family medicine: perspectives of department heads and faculty.
8338453 - Extemporaneous prescribing module 3.
7553113 - Management of late corneal haze following photorefractive keratectomy.
Publication Detail:
Type:  Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of the American Board of Family Medicine : JABFM     Volume:  23     ISSN:  1557-2625     ISO Abbreviation:  J Am Board Fam Med     Publication Date:    2010 Jul-Aug
Date Detail:
Created Date:  2010-07-09     Completed Date:  2010-11-09     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101256526     Medline TA:  J Am Board Fam Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  509-13     Citation Subset:  IM    
Affiliation:
Institute for Family Health, New York, NY, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortifacient Agents, Nonsteroidal / administration & dosage
Abortifacient Agents, Steroidal / administration & dosage
Abortion, Induced / methods*
Adult
Family Practice / methods*
Female
Health Services Research
Humans
Mifepristone / administration & dosage
Misoprostol / administration & dosage
New York
Outcome and Process Assessment (Health Care)
Patient Satisfaction
Pregnancy
Prospective Studies
Reproductive Health Services
Vacuum Curettage
Chemical
Reg. No./Substance:
0/Abortifacient Agents, Nonsteroidal; 0/Abortifacient Agents, Steroidal; 59122-46-2/Misoprostol; 84371-65-3/Mifepristone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Antidepressant Medication Use for Primary Care Patients with and without Medical Comorbidities: A Na...
Next Document:  Unmet dental needs in rural primary care: a clinic-, community-, and practice-based research network...